Human intelligence enhanced by artificial intelligence

A revolution in structural heart identification and management

How are you reducing heart failure readmissions?

How do you know if a structural heart patient has been missed?

How are you reducing heart failure readmissions?

How do you know if a structural heart patient has been missed?

Human intelligence enhanced by artificial intelligence

A revolution in structural heart identification and management

The Solution   

Improving Outcomes

This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.

The Leading Structural Heart Platform Has Expanded into Heart Failure:

Aortic
Stenosis

Mitral
Stenosis

Tricuspid
Regurgitation

Heart
Failure

Aortic
Regurgitation

Mitral
Regurgitation

Aortic
Stenosis

Mitral
Stenosis

Tricuspid
Regurgitation

Heart
Failure

Aortic
Regurgitation

Mitral
Regurgitation

Aortic
Stenosis

Aortic
Regurgitation

Mitral
Stenosis

Mitral
Regurgitation

Tricuspid
Regurgitation

Heart
Failure

Overview  

The CardioCare Platform

Providing a comprehensive view of structural heart patients, now helping heart programs identify their most at-risk patient populations. This leading-edge combination of artificial intelligence solutions and big data analytics help to close gaps that can cause undertreatment in structural heart disease.

contact us

+37%

  • IDENTIFIED
  • Increase in patients meeting severe Aortic Stenosis (AS) criteria per the AHA/ACC guidelines

+29%

  • DIAGNOSED
  • Increase in patients diagnosed with severe AS

+35%

  • REFERRED
  • Increase in patients referred to cardiovascular specialist

+54%

  • THERAPY
  • Increase in patients receiving a therapy plan

**Analysis represents aggregate median performance across 14 sites with baseline data after six months of using the CardioCare program.

Now Introducing

Insights to Help Improve Outcomes for Your Heart Failure Patients

1Early data representing 5 heart programs managing more than 50,000 HFrEF patients. Heart failure with a reduced ejection fraction is defined as (HFrEF) and guideline-directed medical therapy (GDMT) is defined by patients being prescribed all 4 medications to treat heart failure. 2Observed in patients prescribed all 4 guideline-directed medications compared to those with 0 guideline-directed medications.

The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of structural heart diseases.

The Solution   

Improving Outcomes

This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.

Applying Predictive Algorithms to Identify Your Most At-Risk Patients

How it Works

Artificial Intelligence Solutions to Close Gaps in Care

The CardioCare platform is the industry leader in structural heart insights, focused on reducing variability in care and improving guideline-directed treatment through:

Big
Data

Leveraging AI from millions of records to help you understand your hospitals entire structural heart patient population

Insights
On Demand

Prioritizing care for patients eligible for life saving treatment

Predictive Algorithms

Helping physicians identify patients with a higher likelihood of having undiagnosed severe disease

                 * The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of structural heart diseases.

Testimonials

Leading hospitals partner with egnite’s CardioCare program to reduce variability in diagnoses and improve guideline-directed therapy for patients with structural heart disease.

Implementing CardioCare has been a powerful win-win; it’s been a win for our hospital, for our program and for our echo labs, but really, it’s been a win for our patients.
Dr. Maddie Petrescu
Director, Echocardiography Laboratory Swedish Heart and Vascular
Swedish Medical Center
This is the first time in my career I've been able to see this type of information for my program. There is always opportunity to improve, even at academic medical institutions. CardioCare is not just a platform; it's a program that can demonstrate value for structural heart programs at every level.
Dr. Rahul Sharma
Assistant Professor of Medicine, Stanford University
Director of Structural Interventions, Stanford Health Care
CardioCare’s advanced technology provides a data-driven approach to assessing our structural heart patient population, helping us identify patients at risk and provide the care they need throughout the Northwestern Medicine system.
Dr. Patrick McCarthy
Executive Director, Bluhm Cardiovascular Institute
Vice President Northwestern Medical Group Chief, Division of Cardiac Surgery

Resources

view more

Connect with egnite.

Schedule my demo today.

CONTACT US